MapLight Therapeutics

(NASDAQ) MPLT

Current Price$31.93

Market Cap$1.29B

Since IPO (2025)+65%

5 YearN/A

1 YearN/A

1 Month+62%

MapLight Therapeutics Financials at a Glance

Market Cap

$1.29B

Revenue (TTM)

$0.00

Net Income (TTM)

$161.15M

EPS (TTM)

$-3.71

P/E Ratio

-8.15

Dividend

$0.00

Beta (Volatility)

2.24 (High)

Dividend

$0.00

Beta (Volatility)

2.24 (High)

Price

$31.93

Volume

7,141

Open

$30.36

Price

$31.93

Volume

7,141

Open

$30.36

Previous Close

$31.93

Daily Range

$29.91 - $31.93

52-Week Range

$12.24 - $33.28

Dividend

$0.00

Beta (Volatility)

2.24 (High)

Price

$31.93

Volume

7,141

Open

$30.36

Previous Close

$31.93

Daily Range

$29.91 - $31.93

52-Week Range

$12.24 - $33.28

MPLT News

What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data

Jonathan PoncianoApr 22, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MapLight Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

133

CEO

Christopher A. Kroeger, MD, MBA

Website

www.maplightrx.com

Headquarters

Redwood City, CA 94063, US

MPLT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-36%

Return on Assets

-34%

Earnings Yield

-12.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.29B

Shares Outstanding

42.44M

Volume

7.14K

Avg. Volume

243.45K

Financials (TTM)

Gross Profit

$578.00K

Operating Income

$169.08M

EBITDA

$168.50M

Operating Cash Flow

$138.14M

Capital Expenditure

$473.00K

Free Cash Flow

$138.61M

Cash & ST Invst.

$305.10M

Total Debt

$5.80M

MapLight Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$140.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.29B

N/A

Market Cap/Employee

$11.79M

N/A

Employees

109

N/A

Net Income

$79.55M

-274.7%

EBITDA

$83.24M

-268.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$299.30M

+192.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.91M

-15.3%

Short Term Debt

$891.00K

-42.7%

Return on Assets

-33.61%

N/A

Return on Invested Capital

-36.50%

N/A

Free Cash Flow

$47.20M

-118.6%

Operating Cash Flow

$46.83M

-117.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EDSAEdesa Biotech, Inc.

EDSAEdesa Biotech, Inc.$18.27+14.94%

OSRHOSR Holdings, Inc.

OSRHOSR Holdings, Inc.$0.70+52.80%

PMNProMIS Neurosciences, Inc.

PMNProMIS Neurosciences, Inc.$11.04-0.99%

LPCNLipocine Inc.

LPCNLipocine Inc.$2.33+1.75%

TRAWTraws Pharma, Inc.

TRAWTraws Pharma, Inc.$1.43+10.00%

IMRNImmuron Limited

IMRNImmuron Limited$0.82+1.86%

DWTXDogwood Therapeutics, Inc.

DWTXDogwood Therapeutics, Inc.$1.43+5.93%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.91+0.04%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.75+0.10%

Questions About MPLT

What is the current price of MapLight Therapeutics?

MapLight Therapeutics is trading at $31.93 per share.

What is the 52-week range for MapLight Therapeutics?

Over the past 52 weeks, MapLight Therapeutics has traded between $12.24 and $33.28.

How much debt does MapLight Therapeutics have?

As of the most recent reporting period, MapLight Therapeutics reported total debt of $5.80M.

How much cash does MapLight Therapeutics have on hand?

MapLight Therapeutics reported $46.73M in cash and cash equivalents in its most recent financial results.

What is MapLight Therapeutics’s dividend yield?

MapLight Therapeutics does not currently have a dividend yield.

MapLight Therapeutics

MapLight Therapeutics Financials at a Glance

MPLT News

What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MapLight Therapeutics

MPLT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MapLight Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MPLT

What is the current price of MapLight Therapeutics?

What is the 52-week range for MapLight Therapeutics?

How much debt does MapLight Therapeutics have?

How much cash does MapLight Therapeutics have on hand?

What is MapLight Therapeutics’s dividend yield?

Premium Investing Services